Immunogenicity, reactogenicity, and safety of a second booster with BNT162b2 or full-dose mRNA-1273: A randomized VACCELERATE trial in adults aged ≥75 years (EU-COVAT-1-AGED Part B)
-
Published:2024-09
Issue:
Volume:146
Page:107161
-
ISSN:1201-9712
-
Container-title:International Journal of Infectious Diseases
-
language:en
-
Short-container-title:International Journal of Infectious Diseases
Author:
Stemler JannikORCID, Yeghiazaryan Lusine, Stephan ChristophORCID, Mohn Kristin Greve-Isdahl, Carcas-Sansuan Antonio-JoséORCID, Rodriguez Esperanza Romero, Moltó José, Mitxeltorena Itziar Vergara, Welte Tobias, Zablockienė BirutėORCID, Akova Murat, Bethe UllrichORCID, Heringer Sarah, Salmanton-García Jon, Jeck JuliaORCID, Tischmann LeaORCID, Zarrouk MarouanORCID, Cüppers Arnd, Biehl Lena M.ORCID, Grothe Jan, Mellinghoff Sibylle C.ORCID, Nacov Julia A., Neuhann Julia M.ORCID, Sprute Rosanne, Frías-Iniesta Jesús, Negi Riya, Gaillard Colette, Saini Gurvin, León Alejandro García, Mallon Patrick W.G., Lammens Christine, Hotterbeekx An, Loens KatherineORCID, Malhotra-Kumar Surbhi, Goossens Herman, Kumar-Singh Samir, König Franz, Posch Martin, Koehler Philipp, Cornely Oliver A.ORCID
|
|